Home > Insider Trading > Filing (0001691421-20-000014)

Filing Details

Accession Number:: 0001691421-20-000014
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-11-17 17:30:52
Reporting Period:: 2020-11-04

Accepted Time:: 2020-11-17 17:30:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1691421	Lemonade Inc.	LMND	Fire, Marine & Casualty Insurance (6331)	320469673

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1816039	Jorge Espinel	C/O Lemonade, Inc. 5 Crosby Street, 3Rd Floor New York NY 10013	Cbdo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-11-13	20,000	$5.26	20,000	No	4	M	Direct
Common Stock	Disposition	2020-11-13	3,081	$56.04	16,919	No	4	S	Direct
Common Stock	Disposition	2020-11-13	9,915	$57.09	7,004	No	4	S	Direct
Common Stock	Disposition	2020-11-13	3,200	$58.07	3,804	No	4	S	Direct
Common Stock	Disposition	2020-11-13	1,900	$59.34	1,904	No	4	S	Direct
Common Stock	Disposition	2020-11-13	1,904	$59.90	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	STOCK OPTION	Acquisiton	2020-11-04	50,000	$0.00	50,000	$59.70
Common Stock	STOCK OPTION	Disposition	2020-11-13	20,000	$0.00	20,000	$5.26

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
50,000		2030-11-03	No	4	A	Direct
330,000		2028-10-06	No	4	M	Direct

Footnotes

Represents sale pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.54 to $56.47. The reporting person undertakes to provide Lemonade, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.58 to $57.56 The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.61 to $58.595. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.625 to $59.575. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.785 to $60.08. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option will vest and become exercisable as to 25% on November 4, 2022, and in 12 equal quarterly installments thereafter beginning on February 4, 2023.
The option is vested and exercisable as to 175,000 shares, and the remaining shares will vest and become exercisable in eight quarterly installments beginning on January 1, 2021.